4D MOLECULAR THERAPEUTICS IN
FDMT·35104E100·US·Common Stock·Healthcare - Biotechnology-13D/G
FDMT (4D MOLECULAR THERAPEUTICS IN) is held by 88 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($48.9M), RA CAPITAL MANAGEMENT, L.P. ($47M), GOLDMAN SACHS GROUP INC ($39.2M). Net institutional sentiment: Mixed.
88
Holders
Avg rating(21 Elite)
$315.5M
Total Value
49% (97)
Fund Consensus
42 buying - 44 selling
Who's Trading
InsiderKDKirn DavidSell $184KJul 10, 2026
InsiderKDKirn DavidSell $6KJul 10, 2026
InsiderKDKirn DavidSell $548KJul 9, 2026
InsiderBSBizily ScottSell $92KJun 30, 2026
InsiderBSBizily ScottSell $118KJun 23, 2026
InsiderKDKirn DavidSell $1.2MJun 22, 2026
ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
13F: Insider & Congress:
Showing 1-20 of 97
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer